Insta
WHO To Resume Hydroxychloroquine’s Coronavirus Trials After Study Based On Which It Was Stopped Turns Out To Be Dubious
Anti-malarial drug hydroxychloroquine
The World Health Organisation (WHO) on June 3 said that it is resuming hydroxychloroquine coronavirus trials days after temporarily suspending trial of the drug over safety concerns , news agency AFP reported.
“On the basis of the available mortality data... the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.
The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.
Earlier yesterday (Jun 2), two of the world’s leading medical journals, Lancet and New England Journal of Medicine , expressed serious concern about flaws in the data produced by a small firm that the anti-malarial drug hydroxychloroquine is not safe in Covid-19 option. The two journals had published the study.
The finding led to the pause of an important study of hydroxychloroquine by the World Health Organization.
A case-controlled investigation of the Indian Council of Medical Research (ICMR) has revealed that consumption of four or more maintenance doses of hydroxychloroquine has led to a significant decline in the chances of the health workers getting infected with COVID-19.
According to the findings of a new study by Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, the sustained intake of HCQ prophylaxis as well as appropriate PPE use lowers the risk of Covid-19 infection for healthcare workers.
National COVID-19 Task Force in India had earlier recommended Hydroxychloroquine (HCQ), a repurposed antimalarial drug, as prophylaxis, to mitigate the added risk of healthcare workers contracting COVID-19.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
